SEMAX 50mg from Adaptog Peptides is a synthetic heptapeptide derived from a fragment of ACTH (4-10), widely used in cognitive, neuroprotective, and neurotrophic research. Investigators select SEMAX for its documented influence on BDNF expression and neurochemical signalling. Adaptog supplies SEMAX 50mg as a high-purity laboratory reagent suited to studies that require dependable performance across extended protocols.
SEMAX features prominently in nootropic and neuroprotective research because of its modulatory effects on growth-factor expression and central neurotransmitter systems. Adaptog Peptides supplies SEMAX 50mg in a vial size that supports longer experimental timelines and larger sample volumes, giving researchers flexibility across study designs.
Researchers often buy SEMAX 50mg from Adaptog Peptides for studies such as:
Examining BDNF and NGF expression in controlled neural models
Investigating cognitive-related signalling pathways
Studying neuroprotective markers under ischaemic or oxidative stress conditions
Mapping interactions with serotonergic and dopaminergic systems
Because SEMAX intersects neurotrophic biology, cognition research, and neurochemistry, it supports a wide spectrum of investigative work. Adaptog Peptides delivers SEMAX 50mg as a research-grade compound prepared exclusively for qualified laboratory environments. It does not serve any clinical, diagnostic, or therapeutic purpose.
For research use only. Not for human consumption.
Not a researcher? Exit
